1. Casirivimab/imdevimab lack of efficacy against COVID-19 Omicron variant

   News item 15 January 2022 Pages: 1 - 1

2. Janus kinase inhibitors in patients with RA: risk of MACE and cancer

   News item 15 January 2022 Pages: 2 - 2

3. Possible medication error risks with nirmatrelvir+ritonavir

   News item 15 January 2022 Pages: 3 - 3

4. Tenofovir alafenamide-related renal adverse events

   News item 15 January 2022 Pages: 4 - 4

5. Expected rates of adverse events after COVID-19 vaccination in USA

   Clinical study 15 January 2022 Pages: 5 - 5

6. Hormone therapy in transgender adults does not increase risk of diabetes

   Clinical study 15 January 2022 Pages: 6 - 6

7. No safety signals for GSK quadrivalent influenza vaccine

   Clinical study 15 January 2022 Pages: 7 - 7

8. Rare reports of rheumatic disorder flares after COVID-19 vaccination

   Clinical study 15 January 2022 Pages: 8 - 8

9. Rosuvastatin and sacubitril/valsartan-related rhabdomyolysis

   Clinical study 15 January 2022 Pages: 9 - 9

10. Safety profiles of general and local anaesthetics in Italy

    Clinical study 15 January 2022 Pages: 10 - 10

11. Small change in menstrual cycle length after COVID-19 vaccination

    Clinical study 15 January 2022 Pages: 11 - 11

12. Topical glaucoma therapy may increase postoperative failure rate

    Clinical study 15 January 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 15 January 2022 Pages: 13 - 13

14. Abemaciclib

    Case report 15 January 2022 Pages: 14 - 14

15. Acetazolamide

    Case report 15 January 2022 Pages: 15 - 15

16. Acetazolamide/latanoprost/potassium chloride

    Case report 15 January 2022 Pages: 16 - 16

17. Acitretin/ixekizumab

    Case report 15 January 2022 Pages: 17 - 17

18. Ad26.COV2-S/AZD-1222

    Case report 15 January 2022 Pages: 18 - 18

19. Adalimumab

    Case report 15 January 2022 Pages: 19 - 19

20. Adalimumab/etanercept/methotrexate

    Case report 15 January 2022 Pages: 20 - 20

21. Aflibercept

    Case report 15 January 2022 Pages: 21 - 21

22. Agomelatine

    Case report 15 January 2022 Pages: 22 - 22

23. Agomelatine/trazodone

    Case report 15 January 2022 Pages: 23 - 23

24. Alpelisib/trastuzumab

    Case report 15 January 2022 Pages: 24 - 24

25. Aminolevulinic-acid

    Case report 15 January 2022 Pages: 25 - 25

26. Amiodarone/digoxin interaction

    Case report 15 January 2022 Pages: 26 - 26

27. Amisulpride/olanzapine/risperidone

    Case report 15 January 2022 Pages: 27 - 27

28. Amlodipine/enalapril

    Case report 15 January 2022 Pages: 28 - 28

29. Amoxicillin/clavulanic-acid

    Case report 15 January 2022 Pages: 29 - 29

30. Anakinra/immune-globulin/methylprednisolone

    Case report 15 January 2022 Pages: 30 - 30

31. Anti-CD19-CAR-transduced-T-cells

    Case report 15 January 2022 Pages: 31 - 31

32. Anti-cd19-car-transduced-t-cells/ibrutinib

    Case report 15 January 2022 Pages: 32 - 32

33. Anti-infectives/antineoplastics

    Case report 15 January 2022 Pages: 33 - 33

34. Anti-inflammatories/immunosuppressants

    Case report 15 January 2022 Pages: 34 - 34

35. Antibacterials

    Case report 15 January 2022 Pages: 35 - 35

36. Antibacterials

    Case report 15 January 2022 Pages: 36 - 36

37. Antibacterials/antifungals/​fluorometholone

    Case report 15 January 2022 Pages: 37 - 37

38. Antibacterials/antivirals/immunosuppressants

    Case report 15 January 2022 Pages: 38 - 38

39. Antibacterials/ceftazidime/ciprofloxacin

    Case report 15 January 2022 Pages: 39 - 39

40. Antibacterials/loteprednol-etabonate/tobramycin/steroids

    Case report 15 January 2022 Pages: 40 - 40

41. Anticoagulants/aspirin

    Case report 15 January 2022 Pages: 41 - 41

42. Antineoplastics

    Case report 15 January 2022 Pages: 42 - 42

43. Antineoplastics

    Case report 15 January 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 15 January 2022 Pages: 44 - 44

45. Antineoplastics

    Case report 15 January 2022 Pages: 45 - 45

46. Antineoplastics

    Case report 15 January 2022 Pages: 46 - 46

47. Antineoplastics

    Case report 15 January 2022 Pages: 47 - 47

48. Antineoplastics

    Case report 15 January 2022 Pages: 48 - 48

49. Antineoplastics

    Case report 15 January 2022 Pages: 49 - 49

50. Antineoplastics

    Case report 15 January 2022 Pages: 50 - 50